CIK 0001818331 · Large accelerated filer
GeneDx Holdings Corp.
Sign in to watch- Ticker
- WGS
- Exchange
- Nasdaq
- Industry
- Services-Health Services
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851966622
- Phone
- 888-729-1206
- Business address
- 333 LUDLOW STREET, NORTH TOWER, 6TH FLOOR, STAMFORD, CT, 06902
- Former names
- Sema4 Holdings Corp., CM Life Sciences, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,839,245
- in 5 filings
Net −$1,839,245. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-26 | Feeley Kevin CHIEF FINANCIAL OFFICER | Sale | −2,520 | $63.28 | $159K | 37,432 |
| 2026-03-26 | Feeley Kevin CHIEF FINANCIAL OFFICER | Sale | −995 | $64.60 | $64K | 36,437 |
| 2026-03-26 | Feeley Kevin CHIEF FINANCIAL OFFICER | Sale | −1,857 | $65.21 | $121K | 34,580 |
| 2026-03-26 | Feeley Kevin CHIEF FINANCIAL OFFICER | Option exercise · Restricted Stock Unit | −16,250 | 32,500 | ||
| 2026-03-26 | Stueland Katherine CHIEF EXECUTIVE OFFICER | Option exercise | +80,000 | 138,447 | ||
| 2026-03-26 | Stueland Katherine CHIEF EXECUTIVE OFFICER | Sale | −13,229 | $61.29 | $811K | 125,218 |
| 2026-03-26 | Stueland Katherine CHIEF EXECUTIVE OFFICER | Sale | −5,117 | $62.33 | $319K | 120,101 |
| 2026-03-26 | Stueland Katherine CHIEF EXECUTIVE OFFICER | Sale | −13,412 | $63.28 | $849K | 106,689 |
| 2026-03-26 | Stueland Katherine CHIEF EXECUTIVE OFFICER | Sale | −5,292 | $64.60 | $342K | 101,397 |
| 2026-03-26 | Stueland Katherine CHIEF EXECUTIVE OFFICER | Sale | −9,883 | $65.21 | $645K | 91,514 |
| 2026-03-26 | Stueland Katherine CHIEF EXECUTIVE OFFICER | Option exercise · Restricted Stock Unit | −80,000 | 160,000 | ||
| 2026-03-16 | Feeley Kevin CHIEF FINANCIAL OFFICER | Option exercise | +7,197 | 32,854 | ||
| 2026-03-16 | Feeley Kevin CHIEF FINANCIAL OFFICER | Sale | −2,384 | $76.35 | $182K | 30,470 |
| 2026-03-16 | Feeley Kevin CHIEF FINANCIAL OFFICER | Sale | −3,065 | $77.05 | $236K | 27,405 |
| 2026-03-16 | Feeley Kevin CHIEF FINANCIAL OFFICER | Sale | −257 | $77.94 | $20K | 27,148 |
| 2026-03-16 | Feeley Kevin CHIEF FINANCIAL OFFICER | Option exercise · Restricted Stock Unit | −7,197 | 28,787 | ||
| 2026-03-16 | Stueland Katherine CHIEF EXECUTIVE OFFICER | Option exercise | +18,750 | 75,626 | ||
| 2026-03-16 | Stueland Katherine CHIEF EXECUTIVE OFFICER | Sale | −7,178 | $76.35 | $548K | 68,448 |
| 2026-03-16 | Stueland Katherine CHIEF EXECUTIVE OFFICER | Sale | −9,229 | $77.05 | $711K | 59,219 |
| 2026-03-16 | Stueland Katherine CHIEF EXECUTIVE OFFICER | Sale | −772 | $77.94 | $60K | 58,447 |
Page 6 of 23 · 450 trades